Tequin, (Gatifloxacin) is a popular antibiotic used to treat adults with pneumonia, bronchitis, uncomplicated gonorrhea and infections of the urinary tract, kidneys and skin. The drug, which is manufactured by Bristol-Myers Squibb, has recently been linked to dangerous and potentially fatal side effects including hypergylcemia (high blood sugar), hypoglycemia (low blood sugar) and diabetic ketoacidosis.
On May 1, 2006, Bristol-Myers Squibb announced it will cease making and selling its antibiotic Tequin. The drug has recently been linked to serious cases of diabetes and other potentially fatal blood sugar abnormalities.
According to an FDA press release following the February 16, 2006 label change, there have been reports of life-threatening events following the use of Tequin, including a number of fatalities. At this time, a black box warning has only been suggested, and not required by the FDA.
Information about the risks of low blood sugar and high blood sugar were originally added to the WARNINGS section of the U.S. labeling in 2002, nearly three years after Tequin was approved by the FDA. The recent label changes strengthen the existing WARNING on hypoglycemia and hyperglycemia and also include information identifying additional risk factors for developing low/high blood sugar, such as age and the effects of taking other medications with Tequin.
A recent study showed that patients receiving Tequin had more than 16 times higher risk of hyperglycemia as did patients receiving an alternative form of medication.
Tequin Side Effects:
- Hyperglycemia
- Hypoglycemia
- Diabetic ketoacidosis
- Central Nervous System (CNS) side effects including: seizures, dizziness, confusion, tremors, hallucinations, depression, or suicidal thoughts
- Pain, inflammation or rupture of tendons.
If you or a loved one have experienced any side effects from the defective drug Tequin, please call us at 1.800.966.4999 or fill out the form to the right of the page for immediate attention to your case.
